Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

RATIONALE Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections and hospitalizations in infants worldwide. Known risk factors, however, incompletely explain the variability of RSV disease severity, especially among healthy children. We postulate that the severity of RSV infection is influenced by modulation of the host immune response by the local bacterial ecosystem. OBJECTIVES To assess whether specific nasopharyngeal microbiota (clusters) are associated with distinct host transcriptome profiles and disease severity in children less than 2 years of age with RSV infection. METHODS We characterized the nasopharyngeal microbiota profiles of young children with mild and severe RSV disease and healthy children by 16S-rRNA sequencing. In parallel, using multivariable models, we analyzed whole-blood transcriptome profiles to study the relationship between microbial community composition, the RSV-induced host transcriptional response, and clinical disease severity. MEASUREMENTS AND MAIN RESULTS We identified five nasopharyngeal microbiota clusters characterized by enrichment of either Haemophilus influenzae, Streptococcus, Corynebacterium, Moraxella, or Staphylococcus aureus. RSV infection and RSV hospitalization were positively associated with H. influenzae and Streptococcus and negatively associated with S. aureus abundance, independent of age. Children with RSV showed overexpression of IFN-related genes, independent of the microbiota cluster. In addition, transcriptome profiles of children with RSV infection and H. influenzae- and Streptococcus-dominated microbiota were characterized by greater overexpression of genes linked to Toll-like receptor and by neutrophil and macrophage activation and signaling. CONCLUSIONS Our data suggest that interactions between RSV and nasopharyngeal microbiota might modulate the host immune response, potentially affecting clinical disease severity.

[1]  V. Pascual,et al.  Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis. , 2016, American journal of respiratory and critical care medicine.

[2]  O. Ramilo,et al.  Nasopharyngeal bacterial burden and antibiotics: Influence on inflammatory markers and disease severity in infants with respiratory syncytial virus bronchiolitis. , 2015, The Journal of infection.

[3]  Carla M. T. Bauer,et al.  IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. , 2015, American journal of respiratory and critical care medicine.

[4]  L. Bont,et al.  Neutrophils in respiratory syncytial virus infection: A target for asthma prevention , 2015, Journal of Allergy and Clinical Immunology.

[5]  M. Inouye,et al.  The Infant Nasopharyngeal Microbiome Impacts Severity of Lower Respiratory Infection and Risk of Asthma Development , 2015, Cell Host & Microbe.

[6]  C. Bruggeman,et al.  Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[8]  Cécile Viboud,et al.  Association between Respiratory Syncytial Virus Activity and Pneumococcal Disease in Infants: A Time Series Analysis of US Hospitalization Data , 2015, PLoS medicine.

[9]  R. Veenhoven,et al.  Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. , 2014, American journal of respiratory and critical care medicine.

[10]  P. Andrew,et al.  Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. , 2014, American journal of respiratory and critical care medicine.

[11]  Anne L. Wyllie,et al.  Streptococcus pneumoniae in Saliva of Dutch Primary School Children , 2014, PloS one.

[12]  Damien Chaussabel,et al.  Democratizing systems immunology with modular transcriptional repertoire analyses , 2014, Nature Reviews Immunology.

[13]  H. Bisgaard,et al.  Increased risk of pneumonia and bronchiolitis after bacterial colonization of the airways as neonates. , 2013, American journal of respiratory and critical care medicine.

[14]  J. Banchereau,et al.  Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection , 2013, PLoS medicine.

[15]  K. Poehling,et al.  Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of Age , 2013, Pediatrics.

[16]  H. Bisgaard,et al.  Pathogenic bacteria colonizing the airways in asymptomatic neonates stimulates topical inflammatory mediator release. , 2013, American journal of respiratory and critical care medicine.

[17]  Asuncion Mejias,et al.  Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. , 2013, The Journal of infectious diseases.

[18]  R. Veenhoven,et al.  Associations between Pathogens in the Upper Respiratory Tract of Young Children: Interplay between Viruses and Bacteria , 2012, PloS one.

[19]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[20]  E. Wherry,et al.  Commensal bacteria calibrate the activation threshold of innate antiviral immunity. , 2012, Immunity.

[21]  E. Simões,et al.  Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Krzysztof Trzciński,et al.  Deep Sequencing Analyses of Low Density Microbial Communities: Working at the Boundary of Accurate Microbiota Detection , 2012, PloS one.

[23]  A. Curns,et al.  Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006 , 2012, The Pediatric infectious disease journal.

[24]  O. Ramilo,et al.  Decreased Innate Immune Cytokine Responses Correlate With Disease Severity in Children With Respiratory Syncytial Virus and Human Rhinovirus Bronchiolitis , 2012, The Pediatric infectious disease journal.

[25]  A. Iwasaki,et al.  Microbiota regulates immune defense against respiratory tract influenza A virus infection , 2011, Proceedings of the National Academy of Sciences.

[26]  Susan M. Huse,et al.  Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis , 2011, PloS one.

[27]  Rafia Bhore,et al.  Risk Factors in Children Hospitalized With RSV Bronchiolitis Versus Non–RSV Bronchiolitis , 2010, Pediatrics.

[28]  S. Madhi,et al.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis , 2010, The Lancet.

[29]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[30]  J. Jurcisek,et al.  Respiratory syncytial virus‐induced dysregulation of expression of a mucosal β‐defensin augments colonization of the upper airway by non‐typeable Haemophilus influenzae , 2009, Cellular microbiology.

[31]  M. Lipsitch,et al.  Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization , 2008, PLoS pathogens.

[32]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[33]  E. Simões,et al.  Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  C. Macias,et al.  Immunopathogenesis of respiratory syncytial virus bronchiolitis. , 2007, The Journal of infectious diseases.

[35]  J. Stark,et al.  Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection , 2006, Journal of medical virology.

[36]  R. Webby,et al.  Respiratory Viruses Augment the Adhesion of Bacterial Pathogens to Respiratory Epithelium in a Viral Species- and Cell Type-Dependent Manner , 2006, Journal of Virology.

[37]  Shabir A Madhi,et al.  A role for Streptococcus pneumoniae in virus-associated pneumonia , 2004, Nature Medicine.

[38]  A. Selby,et al.  Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis , 2003, Archives of disease in childhood.

[39]  Deborah Ashby,et al.  Respiratory syncytial virus bronchiolitis: Disease severity, interleukin‐8, and virus genotype * , 2002, Pediatric pulmonology.

[40]  B. Mellen,et al.  Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. , 2000, The Journal of pediatrics.

[41]  O. Ramilo,et al.  Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. , 1999, The Pediatric infectious disease journal.

[42]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[43]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[44]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[45]  J. Lötvall,et al.  Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. , 2000, The Journal of allergy and clinical immunology.